@biotechps

Venture capitalist, life sciences, partner @HealthCapVC

healthcap.eu/
Joined April 2010
  • Tweets112
  • Following157
  • Followers159
19Media
Per Samuelsson retweeted
HealthCap@HealthCapVC29 Nov 2021
HealthCap’s 25th company anniversary! HealthCap was founded in Stockholm on November 29th 1996 and has today a financial and industrial track record that we are proud of. Read more: healthcap.eu/1996-2021
2
4
Starkt stöd för @MIPSinside teknologi i hjälmtest utfört av @Folksam Viktigt vid val av skidhjälm att den skyddar mot rotationsvåld. #SthlmTech @HealthCapVC
This Post is from an account that no longer exists. Learn more
3
4
Nordic NED Fundraising Champion @BiotechPS 💐🏅🏆! Nordic Nanovector 26 mUSD and Oncopeptides 60 mUSD in two last days, securing development of innovative new medication for severe illness. Over-subscribed offerings manifest investor support to this endeavor @HealthCapVC
2
6
Go ahead from FDA and EMA to start pivotal phase III trial @wilsonthera A big step towards improved treatment of #WilsonDisease #sthlmtech xitter.cf/HealthCapVC/status/922…
HealthCap@HealthCapVC23 Oct 2017
Wilson Therapeutics reaches agreement with the FDA and EMA to initiate pivotal Phase 3 study in Wilson Disease healthcap.eu/?p=4920
2
4
Novartis crosses FDA finish line with monumental CAR-T leukemia approval fiercepharma.com/pharma/nova…
1
4
Good news for biotech stocks, $GILD makes $12bn cash offer for CAR-T company $KITE @Nasdaq @osloboers @HealthCapVC xitter.cf/kitepharma/status/9021…
Kite, a Gilead Company@KitePharma28 Aug 2017
$KITE acquired by $GILD for $11.9 Billion, $180 per share bit.ly/2vkq01H
1
3
Why invest in European #VentureCapital? Returns on a healthy upward trend, according to latest EIF data. Read more: bit.ly/2v6tGiZ
21
6
FDA Expands CoreValve Indication to Include Intermediate-Risk Patients | tctmd.com tctmd.com/news/fda-expands-c…
1
Good start for @BONESUPPORT_AB on @Nasdaq Sthlm, closed 10% above IPO price @HealthCapVC 41st IPO xitter.cf/bjornodlander/status/8…
Björn Odlander@BjornOdlander21 Jun 2017
Our great management team supporting the @BONESUPPORT_AB stock @Nasdaq today. IPO #41 @HealthCapVC
1
5
TRVX continues to build portfolio of immuno-oncology opportunities @radforsk @osloboers @HealthCapVC xitter.cf/healthcapvc/status/862…
HealthCap@HealthCapVC10 May 2017
Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study healthcap.eu/?p=4509
1
3
Oncopeptides: Ygalo en potentiell blockbuster dlvr.it/NRhL3b
3
1
Wonderful that investors put up money for development of a potential new blockbuster treatment for #cancer @HealthCapVC IPO #38 #STHLMTech xitter.cf/biotechps/status/83431…
Per Samuelsson@biotechps22 Feb 2017
#Oncopeptides CEO Jakob Lindberg @NASDAQ Sthlm #IPO $73m for R&D #MultipleMyeloma @HealthCapVC
5
2
5 mins left as private company, #Oncopeptides waiting for trading to start, $73m for #MultipleMyeloma R&D, @NASDAQ @HealthCapVC
1
1
4
#Oncopeptides CEO Jakob Lindberg @NASDAQ Sthlm #IPO $73m for R&D #MultipleMyeloma @HealthCapVC
1
1
Läkemedelsbolaget blir årets första börsnotering #sthlmtech @SwPrivateequity @HealthCapVC @biotechps di.se/nyheter/lakemedelsbola…
4
1
3
HealthCap IPO #38 in the making, enabling the development of novel treatment for Multiplle #Myeloma . @SwPrivateequity #sthlmtech xitter.cf/HealthCapVC/status/829…
HealthCap@HealthCapVC8 Feb 2017
Oncopeptides AB (publ) announces a listing of its shares on Nasdaq Stockholm healthcap.eu/?p=4194
3
3
Oncopeptides launches IPO on @nasdaq Stockholm, raising funds to develop rx for #multiplemyeloma pts tinyurl.com/ht9exms @HealthCapVC
2
1
#NordicNanovector raises $59m to expand clinical pgm for pts suffering #NonHodgkinLymphoma @HealthCapVC @osloboers tinyurl.com/zsryfa4
1
#NordicNanovector poster @ASH_hematology Betalutin shows good efficacy ORR=63% and duration of response 20.7 m in 35 NHL pts @HealthCapVC
More than 20,000 delegates at @ASH_hematology 2016 San Diego + every imaginable pharma company @HealthCapVC
1
Load more